Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 4095-4100

  Li, Hongmei ^a   Nourbakhsh, Bardia ^a   Ciric, Bogoljub ^a   Zhang, Guang Xian ^a   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 9; INTERLEUKIN 9 MONOCLONAL ANTIBODY; MESSENGER RNA; MONOCLONAL ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55] PEPTIDE; PEPTIDE VACCINE; RECOMBINANT INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL INVASION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMYELINATION; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; EFFECTOR CELL; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; IMMUNOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; INTERLEUKIN-17; INTERLEUKIN-9; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; T-LYMPHOCYTE SUBSETS;

EID: 77957230475     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000986     Document Type: Article

References (48)

1. Steinman, L. 1999. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24:511-514.
2. Segal, B. M. 2010. Th17 cells in autoimmune demyelinating disease. Semin. Immunopathol. 32:71-77.
3. + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205:811-823.
4. Axtell, R. C., B. A. de Jong, K. Boniface, L. F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J. G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16:406-412.
5. Zhang, J. 2007. Yin and yang interplay of IFN-γ in inflammation and autoimmune disease. J. Clin. Invest. 117:871-873.
6. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183:7169-7177.
7. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
8. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
9. Stockinger, B., M. Veldhoen, and B. Martin. 2007. Th17 T cells: linking innate and adaptive immunity. Semin. Immunol. 19:353-361.
10. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177:566-573.
11. Nakae, S., Y. Iwakura, H. Suto, and S. J. Galli. 2007. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81:1258-1268.
12. Hofstetter, H., R. Gold, and H. P. Hartung. 2009. Th17 cells in MS and experimental autoimmune encephalomyelitis. Int. MS J. 16:12-18.
13. Montes, M., X. Zhang, L. Berthelot, D. A. Laplaud, S. Brouard, J. Jin, S. Rogan, D. Armao, V. Jewells, J. P. Soulillou, and S. Markovic-Plese. 2009. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin. Immunol. 130:133-144.
14. Pilette, C., Y. Ouadrhiri, J. Van Snick, J. C. Renauld, P. Staquet, J. P. Vaerman, and Y. Sibille. 2002. Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9. Eur. Respir. J. 20:1198-1205.
15. Matusevicius, D., P. Kivisäkk, B. He, N. Kostulas, V. Ozenci, S. Fredrikson, and H. Link. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5:101-104.
16. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172:146-155.
17. Nowak, E. C., C. T. Weaver, H. Turner, S. Begum-Haque, B. Becher, B. Schreiner, A. J. Coyle, L. H. Kasper, and R. J. Noelle. 2009. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206:1653-1660.
18. Locksley, R. M. 2009. Nine lives: plasticity among T helper cell subsets. J. Exp. Med. 206:1643-1646.
19. Donahue, R. E., Y. C. Yang, and S. C. Clark. 1990. Human P40 T-cell growth factor (interleukin-9) supports erythroid colony formation. Blood 75:2271-2275.
20. Williams, D. E., P. J. Morrissey, D. Y. Mochizuki, P. de Vries, D. Anderson, D. Cosman, H. S. Boswell, S. Cooper, K. H. Grabstein, and H. E. Broxmeyer. 1990. T-cell growth factor P40 promotes the proliferation of myeloid cell lines and enhances erythroid burst formation by normal murine bone marrow cells in vitro. Blood 76:906-911.
21. + natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106:12885-12890.
22. Gessner, A., H. Blum, and M. Röllinghoff. 1993. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189:419-435.
23. Wu, B., C. Huang, M. Kato-Maeda, P. C. Hopewell, C. L. Daley, A. M. Krensky, and C. Clayberger. 2008. IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin. Immunol. 126:202-210.
24. + T cells depends on IL-2, is synergistically enhanced by a combination of TGF-β and IL-4, and is inhibited by IFN-γ. J. Immunol. 153:3989-3996.
25. Cheng, G., M. Arima, K. Honda, H. Hirata, F. Eda, N. Yoshida, F. Fukushima, Y. Ishii, and T. Fukuda. 2002. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 166:409-416.
26. Richard, M., R. K. Grencis, N. E. Humphreys, J. C. Renauld, and J. Van Snick. 2000. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl. Acad. Sci. USA 97:767-772.
27. + dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis. J. Immunol. 181:2483-2493.
28. Nabel, G., S. J. Galli, A. M. Dvorak, H. F. Dvorak, and H. Cantor. 1981. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mastcells. Nature 291:332-334.
29. Gran, B., G. X. Zhang, S. Yu, J. Li, X. H. Chen, E. S. Ventura, M. Kamoun, and A. Rostami. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169:7104-7110.
30. Zhang, G. X., S. Yu, B. Gran, J. Li, I. Siglienti, X. Chen, D. Calida, E. Ventura, M. Kamoun, and A. Rostami. 2003. Role of IL-12 receptor β1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J. Immunol. 171:4485-4492.
31. H17 cell differentiation by antagonizing RORγt function. Nature 453:236-240.
32. + T cells and implications for autoimmunity. J. Neuroimmune Pharmacol. 5:198-209.
33. Uyttenhove, C., R. J. Simpson, and J. Van Snick. 1988. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc. Natl. Acad. Sci. USA 85:6934-6938.
34. Hültner, L., S. Kölsch, M. Stassen, U. Kaspers, J. P. Kremer, R. Mailhammer, J. Moeller, H. Broszeit, and E. Schmitt. 2000. In activated mast cells, IL-1 upregulates the production of several Th2-related cytokines including IL-9. J. Immunol. 164:5556-5563.
35. Finiasz, M. R., M. C. Franco, S. De La Barrera, L. Rutitzky, G. Pizzariello, M. del Carmen Sasiain, J. C. Renauld, J. Van Snick, and S. Fink. 2007. IL-9 promotes anti-Mycobacterium leprae cytotoxicity: involvement of IFNγ. Clin. Exp. Immunol. 147:139-147.
36. Veldhoen, M., C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factor-β "reprograms" the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341-1346.
37. Liu, Y., I. Teige, B. Birnir, and S. Issazadeh-Navikas. 2006. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12:518-525.
38. White, B., F. Leon, W. White, and G. Robbie. 2009. Two first-in-human, openlabel, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers. Clin. Ther. 31:728-740.
39. Engelhardt, B., and R. M. Ransohoff. 2005. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 26:485-495.
40. Dong, Q., J. Louahed, A. Vink, C. D. Sullivan, C. J. Messler, Y. Zhou, A. Haczku, F. Huaux, M. Arras, K. J. Holroyd, et al. 1999. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur. J. Immunol. 29:2130-2139.
41. Emamaullee, J. A., J. Davis, S. Merani, C. Toso, J. F. Elliott, A. Thiesen, and A. M. Shapiro. 2009. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58:1302-1311.
42. Furuzawa-Carballeda, J., M. I. Vargas-Rojas, and A. R. Cabral. 2007. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6:169-175.
43. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951-1957.
44. Aranami, T., and T. Yamamura. 2008. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 57:115-120.
45. Uyttenhove, C., C. Sommereyns, I. Théate, T. Michiels, and J. Van Snick. 2007. Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 1110:330-336.
46. Hültner, L., C. Druez, J. Moeller, C. Uyttenhove, E. Schmitt, E. Rüde, P. Dörmer, and J. Van Snick. 1990. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur. J. Immunol. 20:1413-1416.
47. Sugimoto, T., Y. Ishikawa, T. Yoshimoto, N. Hayashi, J. Fujimoto, and K. Nakanishi. 2004. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J. Exp. Med. 199:535-545.
48. Yoshimoto, T., K. Takeda, T. Tanaka, K. Ohkusu, S. Kashiwamura, H. Okamura, S. Akira, and K. Nakanishi. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J. Immunol. 161:3400-3407.